IFS Advisors LLC Acquires 243 Shares of Cardinal Health, Inc. $CAH

IFS Advisors LLC boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 23.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,280 shares of the company’s stock after acquiring an additional 243 shares during the period. Cardinal Health accounts for about 0.2% of IFS Advisors LLC’s investment portfolio, making the stock its 18th largest position. IFS Advisors LLC’s holdings in Cardinal Health were worth $215,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in CAH. Wellington Management Group LLP lifted its holdings in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI lifted its holdings in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after purchasing an additional 927,950 shares in the last quarter. Nuveen LLC purchased a new position in Cardinal Health during the first quarter valued at approximately $106,065,000. Finally, T. Rowe Price Investment Management Inc. purchased a new position in Cardinal Health during the first quarter valued at approximately $104,951,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Activity at Cardinal Health

In related news, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ola M. Snow sold 28,151 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last quarter. 0.12% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CAH. Bank of America lifted their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the company a “buy” rating in a report on Tuesday, June 10th. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Wells Fargo & Company reissued an “overweight” rating and issued a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Finally, Evercore ISI lowered their target price on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $165.93.

Cardinal Health Stock Down 2.5%

Cardinal Health stock opened at $154.50 on Friday. The company has a market cap of $36.71 billion, a price-to-earnings ratio of 23.95, a PEG ratio of 1.31 and a beta of 0.71. The firm’s fifty day moving average is $152.07 and its 200 day moving average is $150.38. Cardinal Health, Inc. has a 52-week low of $106.98 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.